The focus has been an assessment of two separate, but interlinked policies with four principal objectives which are to: 

  • Assess the extent to which the design of the Policies was relevant and appropriate to achieve their intended objectives
  • Assess the effectiveness and efficiency of the implementation and management of the policies at the global, regional and country levels
  • Assess the extent to which the Policies have achieved their desired results, and to understand the main successes, challenges and lessons learned
  • Provide evidence-based findings to assist in the review and update of the Policies.

The evaluation will contribute to an ongoing review and update of Gavi’s financing and support policies in 2019-20. This review is, in turn, part of the operationalisation of ‘Gavi 5.0’, Gavi’s strategy for the period 2021-25. The ELTRACO Policies are both considered to be of strategic importance in the context of Gavi 5.0 development and planning especially in the context of a changing global health landscape. 


  • ELTRACO policies evaluation: Evaluation Advisory Committee final assessment


  • ELTRACO policies evaluation: CEPA Final report


  • ELTRACO policies evaluation: Evaluation Management Response


Related content

October 16, 2019

Co-financing policy

Co-financing means that countries contribute to the cost of Gavi-supported vaccines by financing some of the required vaccine doses.

October 16, 2019

Eligibility and transitioning policy

Gavi supports the world’s lowest-income countries. The eligibility and transition policy sets out the criteria that determine which countries are eligible to apply for different forms of Gavi support.

Last updated: 12 May 2020

Subscribe to our newsletter